Published online Jan 16, 2016. doi: 10.12998/wjcc.v4.i1.20
Peer-review started: May 2, 2015
First decision: June 3, 2015
Revised: August 20, 2015
Accepted: November 3, 2015
Article in press: November 4, 2015
Published online: January 16, 2016
Processing time: 263 Days and 5.3 Hours
The term “intracystic papillary ductal carcinoma in situ” constitutes only 0.5% to 1% of all breast cancers. It is usually seen in postmenopausal age group. Herein, we are presenting a minireview about this unusual breast malignancy usually difficult to diagnose on clinical grounds and highlighting modalities of diagnosis and management.
Core tip: The oncosurgeon and surgical pathologist should keep in mind this rare type of in situ carcinoma as a differential diagnosis in palpable breast lumps as it often mimics a benign lesion clinically. However, careful histopathological evaluation superadded by immunohistochemistry is an effective tool to arrive at the correct pathological diagnosis to avoid untoward complications related to under diagnosis and/over diagnosis.